A 58-year-old woman from Delhi is found to have a BRCA1 mutation on genetic testing during screening for familial breast cancer. She is currently asymptomatic with normal clinical breast examination and normal mammography. Her mother and sister both had breast cancer diagnosed before age 50. What is the most appropriate next step in management?

Explanation

## BRCA1 Mutation and Breast Cancer Risk **Key Point:** BRCA1 mutations confer a 45–87% lifetime risk of breast cancer and 40–46% risk of ovarian cancer. Management requires a multidisciplinary approach combining surveillance and risk-reducing strategies. ## Management Pathway for BRCA1-Positive Asymptomatic Women ```mermaid flowchart TD A[BRCA1 mutation confirmed] --> B[Genetic counseling] B --> C{Patient preference & risk tolerance} C -->|Surveillance| D[MRI + mammography from age 25-30] C -->|Risk reduction| E[Discuss prophylactic surgery] E --> F[Risk-reducing bilateral mastectomy] E --> G[Risk-reducing salpingo-oophorectomy] D --> H[Annual screening] F --> I[Reconstruction options] G --> J[HRT discussion if premenopausal] ``` ## Why Genetic Counseling and Shared Decision-Making is Correct **High-Yield:** The immediate next step for an asymptomatic BRCA1-positive woman is comprehensive genetic counseling followed by shared decision-making about surveillance versus risk-reducing surgery. This is the standard of care per ASCO, NCCN, and ESMO guidelines. **Clinical Pearl:** BRCA1 mutations are associated with earlier age of onset and higher penetrance than BRCA2. The presence of a strong family history (mother and sister with early-onset disease) further supports the need for aggressive risk management. **Mnemonic: BRCA Management (RISK)** — Refer for counseling, Imaging (MRI + mammography), Surgery (risk-reducing options), Knowledge of ovarian cancer risk **Tip:** Prophylactic surgery is NOT mandatory immediately; it is one option after counseling. Many women choose surveillance first, particularly if premenopausal. ## Why Each Distractor Is Problematic ### Prophylactic Mastectomy Without Counseling While risk-reducing bilateral mastectomy is a valid option (reduces breast cancer risk by ~95%), performing it immediately without genetic counseling, informed consent, and discussion of alternatives violates the principle of shared decision-making. Counseling must precede surgery. ### Tamoxifen + Mammography Only Tamoxifen reduces breast cancer risk by ~50% in BRCA1 carriers but is inferior to MRI-based surveillance or risk-reducing surgery. Mammography alone has poor sensitivity in BRCA1-positive women (dense breast tissue, higher rates of interval cancers). This approach is suboptimal. ### MRI Screening Without Counseling While MRI + mammography is appropriate for surveillance, offering imaging alone without first discussing and counseling the patient about all options (surveillance vs. risk-reducing surgery, ovarian cancer risk, family implications) is incomplete management.